Jeffrey R. Breiter

Statistics

Publications

Citations

637

H-Index

Active since

2000

Affiliations

Eisai (United States)(Current)

Jeffrey R. Breiter is an author at Eisai (United States) specializing in clinical pharmacology, gastrointestinal pharmacology, and gastrointestinal pharmacotherapy.

Publications per year

2000–2005

Publications

Efficacy and safety of esomeprazole compared with omeprazole in GERD patients with erosive esophagitis: a randomized controlled trial

Joel E. Richter, Peter J. Kahrilas, John F. Johanson et al. · The American Journal of Gastroenterology · 2001 · 394 citations

Medicine, Pharmacology, Pharmacotherapy +12

Efficacy and safety of esomeprazole compared with omeprazole in GERD patients with erosive esophagitis: a randomized controlled trial.

Joel E. Richter, Peter J. Kahrilas, Paul N. Maton et al. · PubMed · 2001 · 129 citations

Medicine, Pharmacology, Pharmacotherapy +14

Long‐term prevention of erosive or ulcerative gastro‐oesophageal reflux disease relapse with rabeprazole 10 or 20 mg vs. placebo: results of a 5‐year study in the United States

Antonio Caos, Jeffrey R. Breiter, Carlos Perdomo et al. · Alimentary Pharmacology & Therapeutics · 2005 · 54 citations · Full text

Medicine, Internal Medicine, Pharmacotherapy +12

Rabeprazole for the prevention of recurrent erosive or ulcerative gastro-oesophageal reflux disease

C. Birbara, Jeffrey R. Breiter, Carlos Perdomo et al. · European Journal of Gastroenterology & Hepatology · 2000 · 44 citations

Medicine, Clinical Sciences, Pharmacotherapy +9

Rabeprazole is superior to ranitidine in the management of active duodenal ulcer disease: results of a double-blind, randomized North American study

Jeffrey R. Breiter, Dennis Riff, Thomas J. Humphries · The American Journal of Gastroenterology · 2000 · 16 citations

Medicine, Pharmacology, Pharmacotherapy +14

1–5 of 5